The addition of the Alberta-based pharmacy will set the stage for the production and distribution of pharmaceutical products for Levitee Labs, which will include addiction, depression, and pain management-related products such as prescribed ketamine.
In the last few years, we have seen an uptick in behavioral health groups focused on psychedelic treatments. There are now at least five psychedelic-assisted therapy platforms traded on NASDAQ with numerous others listed on the Toronto Stock Exchange and elsewhere.
Psychedelic biopharmaceutical company GH Research PLC saw its shares pop over 15% in trading after the company was named in a hedge fund purchase.
Mycrodose Therapeutics‘ CEO Chad Conner and Nova Mentis Life Science Corp’s Marvin Hausman discuss the new partnership the two groups have formed to to treat neuroinflammatory disorders, such as fragile X syndrome and autism spectrum disorder with psychedelics.
Cava Healthcare Inc. has announced that it has entered into an agreement to sell its right, title and interest in and the intellectual property rights for use of psychedelics to treat dementia to Mynd Life Sciences Inc..
Italian activists on Thursday formally turned in about 630,000 signatures for a referendum to legalize the personal cultivation of marijuana and other psychoactive plants and fungi like psilocybin mushrooms.
Cybin has announced the launch of the EMBARK Psychedelic Facilitator Training Program.
Awakn Life Sciences Corp. has announced the success of phase one of its new chemical entity development program to strengthen Awakn’s pipeline for the treatment of a broad range of both substance and behavioral addictions.
Psychedelic drugs such as psilocybin, LSD and MDMA have tremendous medical and commercial future potential… and for ketamine, the “future” is now.
Mind Cure Health Inc. has announced the signing of a non-binding letter of intent with Awakn Life Sciences, a biotechnology company with clinical operations researching, developing, and delivering psychedelic medicine to better treat Addiction. The agreement with Awakn allows Mind Cure to to distribute its ketamine-assisted psychotherapy for Alcohol Use Disorder (AUD) protocol in the US and Canada.